Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Gastrointest Endosc. Apr 16, 2024; 16(4): 193-205
Published online Apr 16, 2024. doi: 10.4253/wjge.v16.i4.193
Table 4 Adverse outcome rates in the patient groups, n (%)
Feature
Secondary surgery for completion, n = 36
Surveillance-only strategy, n = 75
P value
Adverse outcomes: Dissemination and/or local recurrence5 (13.9)5 (6.7)0.289
Dissemination5 (13.9)4 (5.3)0.147
Local recurrence2 (5.6)2 (2.7)0.594
Both2 (5.6)1 (1.3)
Tumor progression1 (2.8)1 (1.3)0.546